<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00817245</url>
  </required_header>
  <id_info>
    <org_study_id>86-47</org_study_id>
    <nct_id>NCT00817245</nct_id>
  </id_info>
  <brief_title>Effect of Helicobacter Pylori Treatment on Idiopathic Central Serous Chorioretinopathy (ICSCR)</brief_title>
  <acronym>ICSCR</acronym>
  <official_title>Effect of Helicobacter Pylori Treatment on Remission of Idiopathic Central Serous Chorioretinopathy (ICSCR)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tabriz University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tabriz University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Etiology of ICSCR is not known however recent studies regard the role of immunologic and
      infectious processes in the pathogenesis of ICSCR.one of these hypothesis is the role of
      helicobacter pylori in the pathogenesis of ICSCR so perhaps treatment of h pylori have
      positive effect on the remission of ICSCR.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      we will choose 50 cases of patients with ICSCR who are infected with h.pylori.25 cases will
      receive anti h.pylori regiment and 25 cases as controls will receive no medication.then we
      will compare the time of submacular fluid resorption and macular thickness and visual acuity
      among these two groups.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2008</start_date>
  <completion_date type="Actual">January 2009</completion_date>
  <primary_completion_date type="Actual">October 2008</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Subretinal fluid level</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>time of sub macular fluid absorption</measure>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Central Serous Chorioretinopathy</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Oral Amoxicillin Capsule Metronidazole Tablet Omeprazole Capsule</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No medical treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>omeprazole, Amoxicillin, metronidazole</intervention_name>
    <description>we will evaluate the effect of medication(anti h.pylori) on the remission of ICSCR</description>
    <arm_group_label>1</arm_group_label>
    <other_name>treatment of Central serous chorioretinopathy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  the persons who are infected with helicobacter pylori and have ICSCR

        Exclusion Criteria:

          -  history of previous eye surgery ,to have indication of laser therapy,corticosteroid
             therapy,pregnancy,
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>28 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alireza Javadzadeh</last_name>
    <role>Study Chair</role>
    <affiliation>Alireza Javadzadeh</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Alireza JavadzadehTabriz</name>
      <address>
        <city>Tabriz</city>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>January 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 1, 2009</study_first_submitted>
  <study_first_submitted_qc>January 5, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 6, 2009</study_first_posted>
  <last_update_submitted>January 5, 2009</last_update_submitted>
  <last_update_submitted_qc>January 5, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 6, 2009</last_update_posted>
  <responsible_party>
    <name_title>Alireza Javadzadeh</name_title>
    <organization>Tabriz University of Medical Sciences</organization>
  </responsible_party>
  <keyword>CSR</keyword>
  <keyword>Helicobacter pylori</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Central Serous Chorioretinopathy</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Amoxicillin</mesh_term>
    <mesh_term>Metronidazole</mesh_term>
    <mesh_term>Omeprazole</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>March 2, 2010</submitted>
    <returned>March 26, 2010</returned>
    <submitted>April 12, 2010</submitted>
    <returned>May 11, 2010</returned>
    <submitted>May 21, 2010</submitted>
    <returned>June 22, 2010</returned>
    <submitted>October 6, 2010</submitted>
    <returned>November 4, 2010</returned>
    <submitted>May 22, 2011</submitted>
    <returned>June 20, 2011</returned>
    <submitted>June 23, 2011</submitted>
    <returned>July 20, 2011</returned>
    <submitted>August 8, 2011</submitted>
    <returned>September 8, 2011</returned>
    <submitted>September 22, 2011</submitted>
    <returned>October 26, 2011</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

